stockrowCogent Biosciences, Inc. (COGT) vs Dianthus Therapeutics, Inc. (DNTH)
- Cogent Biosciences, Inc. COGT 31.60 +6.83%
- Dianthus Therapeutics, Inc. DNTH 86.43 +4.12%
Cogent Biosciences, Inc. and Dianthus Therapeutics, Inc. are both Biotechnology companies. Cogent Biosciences, Inc. is the larger, with a market value of $5.1B against $4.6B — 1.1× the size. Cogent Biosciences, Inc. grew revenue faster over the last twelve months: 110.2% against −11.7%. Cogent Biosciences, Inc. has the higher net margin (0.00% vs −7,436.5%) and the higher return on invested capital (0.00% vs −36.6%). Across the 17 metrics below, Cogent Biosciences, Inc. leads on 9 and Dianthus Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | COGT | DNTH | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 68.51% |
| Operating margin | 0.00% | (8,683.89%) | 0.00% |
| Net margin | 0.00% | (7,436.50%) | 0.00% |
| Free cash flow margin | 0.00% | (6,469.87%) | 0.00% |
| Return on equity | (146.55%) | (22.61%) | (51.96%) |
| Return on assets | (68.00%) | (21.81%) | (46.06%) |
| Return on invested capital | 0.00% | (36.55%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack